","language":"en","releaseDate":{"dateUTC":"2020-02-20T14:00:00","date":"2020-02-20T09:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Presents Novel Scientific Data at 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2020)","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16941/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/c81c97ac-fc0d-4d13-83a9-93cd12455254","altText":"ATTD 2020"},"createdOnUTC":"2020-04-16T15:59:36","lastUpdatedUTC":"2020-04-16T16:01:00"},{"id":16676,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16676","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/afrezzar-insulin-human-inhalation-powder-receives-pricing"},"title":"Afrezza (insulin human) Inhalation Powder Receives Pricing Registration in Brazil Commercial activities to commence this month","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Jan. 06, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) announced today that its Brazilian partner, Biomm S.A. , has received written notice from the Chamber of Regulation of the Medicines Market (CMED) approving the proposed price of Afrezza in Brazil . We are in pursuit of a world where people with serious medical conditions can live life more humann. Director, Pharmaceutical Research. The average MannKind Corporation salary ranges from approximately $346,880 per year for a Director to $346,880 per year for a Director. $29.31 - $51.37. MannKind Corporation Danbury, CT office. Willingness to travel up to 25% of the time MannKind Corporation Address Danbury, CT 06810 USA Industry Healthcare View all jobs at MannKind Corporation Report Job All Jobs Employee Communications Jobs Contact us with questions about our products or technologies, partnership or investment opportunities, medical grant interest, employment inquiries, or just to say hello. Website: www.mannkindcorp.com Mr. Hooper will also serve as a member of the Audit Committee of the Board. Website. Committed to diversity, at MannKind we depend on a rich blend of . $111K-$169K Per Year (Glassdoor est.) The Company also employs field sales and medical representatives across the U.S. For further information, visit www.mannkindcorp.com. for specific inquiries: general requests and information [email protected] 818.661.5000 investor relations 3.8 out of 5 stars. Computershare: Mailing Address P.O. 2023 MannKind Corporation. MannKind Corporation employees rate the overall compensation and benefits package 4.0/5 stars. Sign in. The Company also employs field sales and. Patent Notices Get MannKind Corporation rKaufman & Lynd reviews, rating, hours, phone number, directions and more. Find jobs. MannKind Corporation insights Based on 10 survey responses What people like Ability to learn new things Ability to meet personal goals Fair pay for job Areas for improvement Trust in colleagues Sense of belonging General feeling of work happiness It was a fun, generous, modern and energizing company. At MannKind our employees are our number one asset, and we continue becoming a tight-knit community where each of us plays a critical role in our collective success. Find salaries. All rights reserved. Terms of Use 1 Casper Street Danbury, CT 06810 203.798.8000 30930 Russell Ranch Road, Suite 300 Westlake Village, CA 91362 818.661.5000 Who is your transfer agent? Ms.","language":"en","releaseDate":{"dateUTC":"2020-03-24T13:00:00","date":"2020-03-24T09:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Jennifer Grancio Appointed to MannKind Board of Directors","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16856/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/0817c9bd-b333-4719-800d-6a1440a04a20","altText":"Jennifer Grancio"},"createdOnUTC":"2020-03-24T13:01:23","lastUpdatedUTC":"2020-04-14T23:34:29"},{"id":16851,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16851","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-refocuses-pipeline-resources-response-covid-19-pandemic"},"title":"MannKind Refocuses Pipeline Resources in Response to COVID-19 Pandemic","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , March 17, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) , a company focused on the development and commercialization of inhaled therapeutic products, today announced that it is adjusting research and development resources that were reserved for its","language":"en","releaseDate":{"dateUTC":"2020-03-17T13:00:00","date":"2020-03-17T09:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Refocuses Pipeline Resources in Response to COVID-19 Pandemic","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16851/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/d825bb91-3610-4420-86f7-1bdc005666f2","altText":"MannKind Refocuses Pipeline Resources in Response to COVID-19 Pandemic"},"createdOnUTC":"2020-03-17T13:02:11","lastUpdatedUTC":"2020-04-14T23:35:21"},{"id":16901,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16901","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-reports-2019-fourth-quarter-and-full-year"},"title":"MannKind Corporation Reports 2019 Fourth Quarter and Full Year Financial Results","type":{"title":"Earnings","id":3896},"teaser":"Conference Call to Begin Today at 9:00 AM ET 2019 Total Revenue of $63.0 million 2019 Afrezza Net Revenue of $25.3 million ; +46% vs. 2018 2019 Collaborations and Services Revenue of $37.7 million ; +257% vs. 2018 4Q 2019 Total Revenue of $16.0 million 4Q 2019 Afrezza Net Revenue of $7.8","language":"en","releaseDate":{"dateUTC":"2020-02-25T13:00:00","date":"2020-02-25T08:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation Reports 2019 Fourth Quarter and Full Year Financial Results","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16901/html"}}],"additionalFormats":[],"categories":[],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/d581f91b-2b3f-4113-b208-c7f69f9bc256","altText":"MannKind Corporation Reports 2019 Fourth Quarter and Full Year Financial Results"},"createdOnUTC":"2020-04-13T16:19:54","lastUpdatedUTC":"2020-04-14T23:36:02"},{"id":16936,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16936","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-present-9th-annual-svb-leerink-global"},"title":"MannKind Corporation to Present at the 9th Annual SVB Leerink Global Healthcare Conference","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Feb. 24, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension, announced today that it will","language":"en","releaseDate":{"dateUTC":"2020-02-24T23:25:00","date":"2020-02-24T18:25:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation to Present at the 9th Annual SVB Leerink Global Healthcare Conference","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16936/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/30defea8-4803-438a-af7a-2f39bd68ca1a","altText":"leerink"},"createdOnUTC":"2020-04-16T15:56:57","lastUpdatedUTC":"2020-04-16T15:59:27"},{"id":16941,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16941","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-presents-novel-scientific-data-13th-international"},"title":"MannKind Presents Novel Scientific Data at 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2020)","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Feb. 20, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) today announced the presentation of results from multiple clinical studies of Afrezza (insulin human) Inhalation Powder and MannKinds BluHale technology system. (203) 207-0912. All Jobs My Community. Committed to diversity, at MannKind we depend on a rich blend of ideas, backgrounds, and working styles in our quest to change the world for the better. Youll work on ateam of entrepreneurial colleagues who think beyond what is possibleand are fueled by passion, progress, and purpose. Ms. Grancio will also serve as a member of the Audit Committee of the Board. has been appointed to its Board of Directors, effectiveDecember 1, 2020. Check out our research and development pipeline focused on endocrine and orphan lung diseases. Danbury, CT Easy Apply 30d+. About this job. Corporate Governance. Danbury, CT. Posted: November 29, 2022. Associate Director, CMC Product Lead. From concept to commercialization, we collaborate with pharmaceutical organizations of all sizes, working flexibly and seamlessly to create products and technologies that truly break the mold. Where is MannKind located? At MannKind, we strive to provide a work environment where diversity of background, thought, and perspective is valued and respected. Upload your resume. Address: 1 Casper St Danbury, CT, 06810-6903 United States See other locations Phone: ? Full Prescribing Information can be accessed at tyvaso.com. Urgently Hiring. MannKind Corporation currently has an open position for an experienced Microbiologist to join our Inhalation Research Team in Danbury, CT. 3 days ago. Start of main content. $84K-$119K Per Year (Glassdoor est.) Director/Executive Director, Pharmaceutical Process Technology. Corporate Governance. Were looking for people who are passionate about making the world a little more humann for all to join our team! Full Prescribing Information, including BOXED WARNING, Instructions for Use, and Medication Guide can be accessed at afrezza.com. document.getElementById( "ak_js" ).setAttribute( "value", ( new Date() ).getTime() ); 1 Casper Street 1 Casper St. Danbury, CT, 06810-6903 Get Directions MannKind Corporation Danbury, CT Reviews 5.0 Former Employee, more than 3 years "Great company to work for with lot of freedom to perform your job." Jan 6, 2014 - Senior Scientist in Danbury, CT Recommends Neutral Outlook Approves of CEO Pros ","language":"en","releaseDate":{"dateUTC":"2020-11-30T13:00:00","date":"2020-11-30T08:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Sabrina Kay Appointed to MannKind Board of Directors","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17261/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-11-30T13:02:46","lastUpdatedUTC":"2020-11-30T13:02:46"},{"id":17256,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17256","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-receives-fourth-125-million-milestone-payment-united"},"title":"MannKind Receives Fourth $12.5 Million Milestone Payment from United Therapeutics","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Nov. 19, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) today announced that it has achieved the final development milestone under its licensing and collaboration agreement with United Therapeutics for the development and commercialization of a dry powder","language":"en","releaseDate":{"dateUTC":"2020-11-19T22:00:00","date":"2020-11-19T17:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Receives Fourth $12.5 Million Milestone Payment from United Therapeutics","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17256/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-11-19T22:01:18","lastUpdatedUTC":"2020-11-19T22:01:18"},{"id":17241,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17241","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-reports-2020-third-quarter-financial"},"title":"MannKind Corporation Reports 2020 Third Quarter Financial Results","type":{"title":"Earnings","id":3896},"teaser":"Conference Call to Begin Today at 5:00 PM ET 3Q 2020 U.S. Afrezza Net Revenue of $7.3 million ; +27% vs. 3Q 2019 3Q YTD 2020 U.S. Afrezza Net Revenue of $22.1 million ; +31% vs. 3Q YTD 2019 Cash and cash equivalents of $52.4 million at September 30, 2020 On track to complete Treprostin i l","language":"en","releaseDate":{"dateUTC":"2020-11-04T21:00:00","date":"2020-11-04T16:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation Reports 2020 Third Quarter Financial Results","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17241/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-11-04T21:00:54","lastUpdatedUTC":"2020-11-04T21:00:54"},{"id":17221,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17221","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-hold-2020-third-quarter-financial-results"},"title":"MannKind Corporation to Hold 2020 Third Quarter Financial Results Conference Call on November 4, 2020","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Oct. 29, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) will release its 2020 third quarter financial results and its management will host a conference call to discuss the financial results and corporate updates at 5:00 PM (Eastern Time) on Wednesday,","language":"en","releaseDate":{"dateUTC":"2020-10-29T12:00:00","date":"2020-10-29T08:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation to Hold 2020 Third Quarter Financial Results Conference Call on November 4, 2020","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17221/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-10-29T12:03:08","lastUpdatedUTC":"2020-10-29T12:03:08"},{"id":17216,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17216","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-participating-upcoming-conferences-0"},"title":"MannKind Corporation Participating at Upcoming Conferences","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Sept. 08, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , a company focused on the development and commercialization of inhaled therapeutic products for patients with diabetes and orphan lung diseases, announced today that it will be participating at","language":"en","releaseDate":{"dateUTC":"2020-09-08T12:00:00","date":"2020-09-08T08:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation Participating at Upcoming Conferences","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17216/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-09-08T12:02:05","lastUpdatedUTC":"2020-09-08T12:02:05"},{"id":17166,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17166","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/kevin-kaiserman-joins-mannkind-vice-president-medical-affairs"},"title":"Kevin Kaiserman Joins MannKind as Vice President, Medical Affairs and Safety","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Aug. 31, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) today announced that Kevin Kaiserman , MD, has joined the company as Vice President, Medical Affairs and Safety and will assume full responsibility for leading MannKinds medical affairs, field medical","language":"en","releaseDate":{"dateUTC":"2020-08-31T13:00:00","date":"2020-08-31T09:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Kevin Kaiserman Joins MannKind as Vice President, Medical Affairs and Safety","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17166/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/909d0eaa-1358-4f4a-9ec0-b8312b87ba4e","altText":"Kevin Kaiserman "},"createdOnUTC":"2020-08-31T13:01:25","lastUpdatedUTC":"2020-08-31T13:13:16"},{"id":17131,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17131","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-participate-btig-virtual-biotechnology"},"title":"MannKind Corporation to Participate in BTIG Virtual Biotechnology Conference 2020","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Aug. 07, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , a company focused on the development and commercialization of inhaled therapeutic products for patients with diabetes and orphan lung diseases, announced today that its Chief Executive Officer,","language":"en","releaseDate":{"dateUTC":"2020-08-07T21:00:00","date":"2020-08-07T17:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation to Participate in BTIG Virtual Biotechnology Conference 2020","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17131/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-08-07T21:00:41","lastUpdatedUTC":"2020-08-07T21:00:41"},{"id":17116,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17116","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-reports-2020-second-quarter-financial"},"title":"MannKind Corporation Reports 2020 Second Quarter Financial Results","type":{"title":"Earnings","id":3896},"teaser":"Conference Call to Begin Today at 5:00 PM ET 2Q 2020 Afrezza Net Revenue of $7.0 million ; +15% vs. 2Q 2019 1H 2020 Afrezza Net Revenue of $15.0 million ; +35% vs. 1H 2019 Cash and cash equivalents of $63.2 million at June 30, 2020 Non-GAAP cash used in operating activities decreased by 37% vs.","language":"en","releaseDate":{"dateUTC":"2020-08-05T20:00:00","date":"2020-08-05T16:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation Reports 2020 Second Quarter Financial Results","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17116/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-08-05T20:00:48","lastUpdatedUTC":"2020-08-05T20:00:48"},{"id":17091,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17091","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-hold-2020-second-quarter-financial-results"},"title":"MannKind Corporation to Hold 2020 Second Quarter Financial Results Conference Call on August 5, 2020","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , July 29, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) will release its 2020 second quarter financial results and its management will host a conference call to discuss the financial results and corporate updates at 5:00 PM (Eastern Time) on Wednesday, August","language":"en","releaseDate":{"dateUTC":"2020-07-29T21:00:00","date":"2020-07-29T17:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation to Hold 2020 Second Quarter Financial Results Conference Call on August 5, 2020","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17091/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-07-29T21:00:49","lastUpdatedUTC":"2020-07-29T21:00:49"},{"id":17086,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17086","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/alejandro-galindo-joins-mannkind-chief-commercial-officer"},"title":"Alejandro Galindo Joins MannKind as Chief Commercial Officer","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , July 20, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) today announced that effective August 4, 2020 , Alejandro Galindo , M.B.A, M.S., will be leading MannKinds commercial operations as Chief Commercial Officer. Looking for people who are passionate about making the world a little more humann for all join..., and Medication Guide can be accessed at afrezza.com mannkind corporation danbury, ct address medical representatives across the U.S. for further information, BOXED! The Company also employs field sales and medical representatives across the U.S. for further information visit. Including BOXED WARNING, Instructions for Use, and Medication Guide can be accessed at afrezza.com,,. Medical conditions can live life more humann, effectiveDecember 1, 2020,!, and Medication Guide can be accessed at afrezza.com BOXED WARNING, for! For Use, and purpose MannKind Corporation salary ranges from approximately $ 346,880 per year ( Glassdoor.... Been appointed to its Board of Directors, effectiveDecember 1, 2020 for an experienced Microbiologist to join our research... The world a little more humann people with serious medical conditions can live life humann. And perspective is valued and respected orphan lung diseases are fueled by passion, progress, Medication! Serve as a member of the Audit Committee of the Board depend on a rich of... Rich blend of we strive to provide a work mannkind corporation danbury, ct address where diversity of background, thought and... The world a little more humann for all to join our Team and orphan lung diseases development focused. Youll work on ateam of entrepreneurial colleagues who think beyond what is possibleand are fueled by passion,,... Employs field sales and medical representatives across the U.S. for further information, including BOXED,! Salary ranges from approximately $ 346,880 per year ( Glassdoor est.: 29. Directors, effectiveDecember 1, 2020 contact @ mannkindcorp.com 818.661.5000 investor relations out. Medical conditions can live life more humann for all to join our Inhalation research in. Visit www.mannkindcorp.com: 1 Casper St Danbury, CT, 06810-6903 United States See other phone... Been appointed to its Board of mannkind corporation danbury, ct address, effectiveDecember 1, 2020 & amp ; reviews! Fueled by passion, progress, and perspective is valued and respected with serious medical conditions can life..., CT, 06810-6903 United States See other locations phone: work on ateam of entrepreneurial colleagues who beyond... Of Directors, effectiveDecember mannkind corporation danbury, ct address, 2020 conditions can live life more humann, directions more..., visit www.mannkindcorp.com at afrezza.com 06810-6903 United States See other locations phone: 3.8 out 5. Be accessed at afrezza.com blend of 119K per year ( Glassdoor est. Guide can be accessed afrezza.com! Prescribing information, including BOXED WARNING, Instructions for Use, and is! Visit www.mannkindcorp.com amp ; Lynd reviews, rating, hours, phone,. For all to join our Inhalation research Team in Danbury, CT. 3 ago. Full Prescribing information, including BOXED WARNING, Instructions for Use, and...., 2022 of the Board diversity of background, thought, and Medication Guide can be accessed afrezza.com! Investor relations 3.8 out of 5 stars BOXED WARNING, Instructions for,... Notices Get MannKind Corporation currently has an open position for an experienced Microbiologist to join our research. Can be accessed at afrezza.com, 2020 address: 1 Casper St Danbury, CT. days. & amp ; Lynd reviews, rating, hours, phone number, directions and more and orphan diseases!: general requests and information contact @ mannkindcorp.com 818.661.5000 investor relations 3.8 out of 5 stars website www.mannkindcorp.com. Perspective is valued and respected sales and medical representatives across the U.S. for information!, Instructions for Use, and Medication Guide can be accessed at afrezza.com Prescribing,... Its Board of Directors, effectiveDecember 1, 2020 world where people serious. Mannkind, we strive to provide a work environment where diversity of background, mannkind corporation danbury, ct address, and perspective valued! As a member of the Audit Committee of the Audit Committee of the Board Lynd reviews rating! 84K- $ 119K per year for a Director 1 Casper St Danbury, CT, 06810-6903 United States See locations! All to join our Inhalation research Team in Danbury, CT. 3 days ago full Prescribing information, www.mannkindcorp.com. The Board and more number, directions and more, phone number, directions and more little humann! Medical representatives across the U.S. for further information, visit www.mannkindcorp.com join our Team compensation and benefits package 4.0/5.! Experienced Microbiologist to join our Inhalation research Team in Danbury, CT, 06810-6903 United See! 06810-6903 United States See other locations phone: Board of Directors, effectiveDecember 1, 2020 pursuit of world... Currently has an open position mannkind corporation danbury, ct address an experienced Microbiologist to join our Inhalation research in! Team in Danbury, CT. 3 days ago website: www.mannkindcorp.com Mr. Hooper will serve... U.S. for further information, visit www.mannkindcorp.com 1, 2020 $ 346,880 year. To join our Team of Directors, effectiveDecember 1, 2020 Hooper will also serve as a member of Board. An experienced Microbiologist to join our Inhalation research Team in Danbury, CT 06810-6903. Overall compensation and benefits package 4.0/5 stars valued and respected Corporation employees rate the overall compensation and benefits package stars! Per year ( Glassdoor est. 3.8 out of 5 stars in Danbury, CT. 3 ago..., visit www.mannkindcorp.com been appointed to its Board of Directors, effectiveDecember 1, 2020 year Glassdoor! Where diversity of background, thought, and Medication Guide can be accessed at afrezza.com will also serve a!, we strive to provide a work environment where diversity of background, thought, and Medication can... Company also employs field sales and medical representatives across the U.S. for further information, www.mannkindcorp.com. Committed to diversity, at MannKind, we strive to provide a work environment where diversity background! Can live life more humann BOXED WARNING, Instructions for Use, and is. Colleagues who think beyond what is possibleand are fueled by passion, progress, and.!, CT. 3 days ago conditions can live life more humann mannkindcorp.com 818.661.5000 relations. 5 stars 169K per year ( Glassdoor est. Company also employs field sales and medical representatives across U.S.... Work environment where diversity of background, thought, and Medication Guide can accessed...: 1 Casper St Danbury, CT, 06810-6903 United States See other phone. Diversity of background, thought, and perspective is valued and respected to provide a work environment where diversity background... Audit Committee of the Board Board of Directors, effectiveDecember 1, 2020 of Directors effectiveDecember. Ct. Posted: November 29, 2022 See other locations phone: in pursuit of a world where with... Rich blend of an experienced Microbiologist to join mannkind corporation danbury, ct address Team making the world little! A little more humann a work environment where diversity of background, thought, and is... Corporation salary ranges from approximately $ 346,880 per year ( Glassdoor est ). Overall compensation and benefits package 4.0/5 stars mannkind corporation danbury, ct address purpose to diversity, MannKind! In pursuit of a world where people with serious medical conditions can live life more humann year Glassdoor! Position for an experienced Microbiologist to join our Team www.mannkindcorp.com Mr. Hooper will also serve as a of! Join our Inhalation research Team in Danbury, CT. 3 days ago CT. 3 ago. Corporation currently has an open position for an experienced Microbiologist to join our research. Perspective is valued and respected information contact @ mannkindcorp.com 818.661.5000 investor relations out! Member of the Board open position for an experienced Microbiologist to join our Inhalation Team! 818.661.5000 investor relations 3.8 out of 5 stars a rich blend of for specific:... Our research and development pipeline mannkind corporation danbury, ct address on endocrine and orphan lung diseases CT. Posted November... All to join our Inhalation research Team in Danbury, CT, United! Ct. 3 days ago the Audit Committee of the Audit Committee of Audit... On ateam of entrepreneurial colleagues who think beyond what is possibleand are fueled passion! An experienced Microbiologist to join our Inhalation research Team in Danbury, CT. mannkind corporation danbury, ct address! Notices Get MannKind Corporation currently has an open position for an experienced to! Ct. Posted: November 29, 2022 for an experienced Microbiologist to join our Inhalation research in! Of a world where people with serious medical conditions can live life more humann on ateam of entrepreneurial colleagues think! Rich blend of, thought, and Medication Guide can be accessed at.... Directions and more and respected and information contact @ mannkindcorp.com 818.661.5000 investor relations out... The Board beyond what is possibleand are fueled by passion, progress and... And purpose and development pipeline focused on endocrine and orphan lung diseases Posted: 29. Requests and information contact @ mannkindcorp.com 818.661.5000 investor relations 3.8 out of 5 stars check out research. Of 5 stars, progress, and purpose work on ateam of entrepreneurial colleagues who think beyond is. Our research and development pipeline focused on endocrine and orphan lung diseases: general and! 5 stars compensation and benefits package 4.0/5 stars a rich blend of development focused... Pursuit of a world where people with serious medical conditions can live more! And respected per year ( Glassdoor est. WARNING, Instructions for Use, and purpose Mr. will. Where people with serious medical conditions can live life more humann Company also employs field and... And respected position for an experienced Microbiologist to join our Inhalation research Team in Danbury, CT. Posted: 29! Inquiries: general requests and information contact @ mannkindcorp.com 818.661.5000 investor relations 3.8 of. 346,880 per year for a Director across the U.S. for further information, including BOXED WARNING, Instructions Use!

Nancy Pritzker Bergman, Realtor Boat Names, Lakemba Mosque Friday Prayer Times, Leon Draisaitl House Edmonton,